Hedge Fund Accused Of Extortion Loses AIA Review Bid
Ferrum Ferro Capital LLC's bid to invalidate a patent on Allergan Inc.'s glaucoma drug Combigan under the America Invents Act has fallen short, as the Patent Trial and Appeal Board ruled...To view the full article, register now.
Already a subscriber? Click here to view full article